Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes-Reference-Cited by-同舟云学术

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

Published:2018-01-24 Issue:7690 Volume:554 Page:62-68
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Mueller Sebastian,Engleitner Thomas,Maresch Roman,Zukowska Magdalena,Lange Sebastian,Kaltenbacher Thorsten,Konukiewitz Björn,Öllinger Rupert,Zwiebel Maximilian,Strong Alex,Yen Hsi-Yu,Banerjee Ruby,Louzada Sandra,Fu Beiyuan,Seidler Barbara,Götzfried Juliana,Schuck Kathleen,Hassan Zonera,Arbeiter Andreas,Schönhuber Nina,Klein Sabine,Veltkamp Christian,Friedrich Mathias,Rad Lena,Barenboim Maxim,Ziegenhain Christoph,Hess Julia,Dovey Oliver M.,Eser Stefan,Parekh Swati,Constantino-Casas Fernando,de la Rosa Jorge,Sierra Marta I.,Fraga Mario,Mayerle Julia,Klöppel Günter,Cadiñanos Juan,Liu Pentao,Vassiliou George,Weichert Wilko,Steiger Katja,Enard Wolfgang,Schmid Roland M.,Yang Fengtang,Unger Kristian,Schneider Günter,Varela Ignacio,Bradley Allan,Saur Dieter,Rad Roland

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature25459.pdf

Reference63 articles.

1. Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014)

2. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008)

3. Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109–1113 (2010)

4. Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012)

5. Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501 (2015)

Cited by 309 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer;Radiotherapy and Oncology;2024-02

2. Cell of Origin of Pancreatic cancer;Pancreas;2024-01-29

3. Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives;International Journal of Molecular Sciences;2024-01-28

4. Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy;Nature Cancer;2024-01-24

5. KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo;Nature Communications;2024-01-02